Development of health economics in Hungary between 1990-2006

European Journal of Health Economics

Volumn 7, Issue SUPPL. 1, 2006, Pages 4-6

  Boncz, Imre ^a,b   Dózsa, Csaba ^c   Kaló, Zoltán ^d   Nagy, László ^e   Borcsek, Barbara ^c   Brandtmüller, Ágnes ^f   Betlehem, József ^b   Sebestyén, Andor ^g   Gulácsi, László ^f  

^a National Health Insurance Fund Administration OEP   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c Ministry of Health   (Hungary)

^d Novartis   (Hungary)

^e MSD   (Hungary)

^f Institute of Entrepreneurship and Innovation   (Hungary)

^g South Transdanubian Regional Health Insurance Fund Administration   (Hungary)

Author keywords

Health care financing; Health economics; Health insurance; Health services research; Hungary

Indexed keywords

DECISION MAKING; HEALTH CARE FINANCING; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH INSURANCE; HEALTH SERVICES RESEARCH; HUNGARY; PRIORITY JOURNAL; REVIEW;

EID: 33947400499     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-006-0364-z     Document Type: Review

References (32)

1. Deppe HU, Oreskovic S (2006) Back to Europe: Back to Bismarck? Int J Health Serv 26(4):777-802
2. Boncz I (2005) An overview of the Hungarian healthcare. Hospital 7(3):41-42
3. Gulacsi L, Boncz I, Drummond M (2004) Issues for countries considering introducing the "fourth hurdle": The case of Hungary. Int J Technol Assess Health Care 20:337-341
4. Szende A, Mogyorosy Z, Muszbek N, et al. (2002) Methodological guidelines for conducting economic evaluation of healthcare interventions in Hungary: a Hungarian proposal for methodology standards. Eur J Health Econom 3:196-202
5. Dozsa C, Borcsek B, Boncz I, et al. (2005) Experiences of Adoption of the Directive 89/105/EEC of the Council of the European Communities on Transparency in Hungary. Italian Journal of Public Health 3(S1):139
6. Gulacsi L, David T, Dozsa C (2002) Pricing and reimburse ment of drugs and medical devices in Hungary. Eur J Health Econom 3(4):271-278
7. Boncz I, Nagy J, Sebestyen A, Korosi L (2004) Financing of health care services in Hungary. Eur J Health Econom 5(3):252-258
8. Szende A, Mogyorosy Z. (2004) Health care provider payment mechanisms in the new EU members of Central Europe and the Baltic states. Current reforms, incentives, and challenges. Eur J Health Econom 5(3):259-62
9. Gaal P, Belli PC, McKee M, Szocska M (2006) Informal payments for health care: definitions, distinctions, and dilemmas. J Health Polit Policy Law 31(2):251-93
10. Gaal P, Evetovits T, McKee M (2006) Informal payment for health care: Evidence from Hungary. Health Policy 77(1):86-102
11. Gaal P, McKee M (2005) Fee-for-service or donation? Hungarian perspectives on informal payment for health care. Soc Sci Med 60(7):1445-57
12. Szende A, Culyer AJ (2006) The inequity of informal payments for health care: the case of Hungary. Health Policy 75(3):262-71
13. Gulacsi L (2001) Hungarian health care in transition; Studies on the improvement of the effectiveness of health care in Hungary by implementing quality assurance. University of Amsterdam.
14. Banta D, Gulacsi L (2001) The need for cost-effective quality improvement interventions. Eurohealth 6(5):27-28.
15. Gulacsi L, Kovacs A, Janeski J (1994) Quality Assurance in Hungarian Hospitals: A New Focus for Management Development. J Health Adm Educ 12(4):551-559
16. Gulacsi L (1999) Motivated for improvement. Int J Qual Health Care 11(2):174-176
17. Gulacsi L (2001) Health technology assessment in Central and Eastern Europe. Eurohealth 7(1)3-5
18. Kalo Z, Jaray J, Nagy J (2001) Economic evaluation of kidney transplantation versus hemodialysis in patients with end-stage renal disease in Hungary. Prog Transplant 11(3):188-93
19. Kalo Z (2003) Economic aspects of renal transplantation. Transplant Proc 35(3):1223-6
20. Mogyorosy Z, Mucsi I, Rosivall L (2003) Renal replacement therapy in Hungary: the decade of transition. Nephrol Dial Transplant 18:1066-1071.
21. Boncz I (2006) Prevention of cervical cancer in low-resource settings. JAMA 295(11):1248.
22. Boncz I, Sebestyén A, Döbrossy L, Ottó S (2006) The role of immunochemical testing for colorectal cancer. Lancet Oncol 7(5):363-364.
23. Boncz I, Sebestyen A, Hoffer G et al. (2006) Cost implications of the first year of the Hungarian nation wide breast cancer screening programme. EJC Suppl 4(2):56-57
24. Lovas K, Kalo Z, McKenna SP, Whalley D, Pentek M, Genti G (2003) Establishing a standard for patient-completed instrument adaptations in Eastern Europe: experience with the Nottingham Health Profile in Hungary. Health Policy 63(1):49-61
25. Szende A, Leidy NK, Revicki D (2005) Health-related quality of life and other patient-reported outcomes in the European centralized drug regulatory process: a review of guidance documents and performed authorizations of medicinal products 1995 to 2003. Value Health 8(5):534-48
26. Sebestyen A, Boncz I, David T, Toth F, Nyarady J (2005) Total insurance cost of treatment of hip fractures according to the load stability of different surgical methods. Value in Health 8(6): A219
27. Sebestyen A, Boncz I, Borzsei L, Nyarady J (2005) DRG-based cost analysis of femur neck fractures in patients with and without complications using the Hungarian HBCs system. Eur Surg Res 37(S1):18
28. Sebestyen A, Boncz I, Dozsa C, Toth F, Nyarady J (2004) Analysis of femur neck fracture in Hungary from professional, public health and health economics point of view. Eur J Trauma 30(S1):174
29. Szocska MK, Rethelyi JM, Normand C (2005) Managing health care reform in Hungary: challenges and opportunities. BMJ 331(7510):231-3
30. Gulacsi L, Boncz I, Kovacs A (2004) The impacts of the EU enlargement on the Hungarian Health care system. Tijdschrift voor Gezondheidswetenschappen 82(5):281-284
31. Boncz I, Sebestyen A (2006) Compensation for vaccine injury in Hungary. Lancet 367(9517):1144
32. Borcsek B, Boncz I, Dozsa C, Nagy J, Reszegi C (2005) A. The Systematic literature review of the gamma knife. Italian Journal of Public Health 3(S1):178